These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31532503)

  • 41. Similarities and differences in gastrointestinal physiology between neonates and adults: a physiologically based pharmacokinetic modeling perspective.
    Yu G; Zheng QS; Li GF
    AAPS J; 2014 Nov; 16(6):1162-6. PubMed ID: 25182208
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients.
    de Wildt SN; de Hoog M; Vinks AA; van der Giesen E; van den Anker JN
    Crit Care Med; 2003 Jul; 31(7):1952-8. PubMed ID: 12847388
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock.
    De Paepe P; Belpaire FM; Buylaert WA
    Clin Pharmacokinet; 2002; 41(14):1135-51. PubMed ID: 12405864
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Maturation of Oxycodone Pharmacokinetics in Neonates and Infants: a Population Pharmacokinetic Model of Three Clinical Trials.
    Välitalo P; Kokki M; Ranta VP; Olkkola KT; Hooker AC; Kokki H
    Pharm Res; 2017 May; 34(5):1125-1133. PubMed ID: 28205004
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Developmental pharmacokinetics.
    van den Anker JN; Schwab M; Kearns GL
    Handb Exp Pharmacol; 2011; 205():51-75. PubMed ID: 21882105
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ontogeny of ADME Processes during Postnatal Development in Man and Preclinical Species: A Comprehensive Review.
    De Schaepdrijver LM; Annaert PPJ; Chen CL
    Drug Metab Dispos; 2019 Mar; 47(3):295. PubMed ID: 30770345
    [No Abstract]   [Full Text] [Related]  

  • 47. Pharmacokinetics of anti-infective agents in paediatric patients.
    Butler DR; Kuhn RJ; Chandler MH
    Clin Pharmacokinet; 1994 May; 26(5):374-95. PubMed ID: 8055682
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Pharmacokinetic aspects of pediatric drug therapy].
    Pokrajac M
    Srp Arh Celok Lek; 1995 Jun; 123 Suppl 1():22-6. PubMed ID: 18193797
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Incorporating pharmacokinetic differences between children and adults in assessing children's risks to environmental toxicants.
    Ginsberg G; Hattis D; Sonawane B
    Toxicol Appl Pharmacol; 2004 Jul; 198(2):164-83. PubMed ID: 15236952
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetic Considerations in Designing Pediatric Studies of Proteins, Antibodies, and Plasma-Derived Products.
    Mahmood I
    Am J Ther; 2016; 23(4):e1043-56. PubMed ID: 27386959
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics of proton pump inhibitors in children.
    Litalien C; Théorêt Y; Faure C
    Clin Pharmacokinet; 2005; 44(5):441-66. PubMed ID: 15871633
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug Dosing and Pharmacokinetics in Children With Obesity: A Systematic Review.
    Harskamp-van Ginkel MW; Hill KD; Becker KC; Testoni D; Cohen-Wolkowiez M; Gonzalez D; Barrett JS; Benjamin DK; Siegel DA; Banks P; Watt KM;
    JAMA Pediatr; 2015 Jul; 169(7):678-85. PubMed ID: 25961828
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of exercise on the pharmacokinetics of drugs.
    Khazaeinia T; Ramsey AA; Tam YK
    J Pharm Pharm Sci; 2000; 3(3):292-302. PubMed ID: 11293389
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Understanding dosing: children are small adults, neonates are immature children.
    Anderson BJ; Holford NH
    Arch Dis Child; 2013 Sep; 98(9):737-44. PubMed ID: 23832061
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Back to basics: understanding drugs in children: pharmacokinetic maturation.
    Tetelbaum M; Finkelstein Y; Nava-Ocampo AA; Koren G
    Pediatr Rev; 2005 Sep; 26(9):321-8. PubMed ID: 16140874
    [No Abstract]   [Full Text] [Related]  

  • 56. Semi-Mechanistic Model for Predicting the Dosing Rate in Children and Neonates for Drugs Mainly Eliminated by Cytochrome Metabolism.
    Cerruti L; Bleyzac N; Tod M
    Clin Pharmacokinet; 2018 Jul; 57(7):831-841. PubMed ID: 28889370
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Theoretical pharmacokinetic drug alterations in pediatric celiac disease.
    Tran TH; Smith C; Mangione RA
    Expert Opin Drug Metab Toxicol; 2015; 11(10):1539-50. PubMed ID: 26155875
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acetaminophen developmental pharmacokinetics in premature neonates and infants: a pooled population analysis.
    Anderson BJ; van Lingen RA; Hansen TG; Lin YC; Holford NH
    Anesthesiology; 2002 Jun; 96(6):1336-45. PubMed ID: 12170045
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives.
    Lau AH; Lam NP; Piscitelli SC; Wilkes L; Danziger LH
    Clin Pharmacokinet; 1992 Nov; 23(5):328-64. PubMed ID: 1478003
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antimicrobial therapy in neonates, infants and children.
    Brown RD; Campoli-Richards DM
    Clin Pharmacokinet; 1989; 17 Suppl 1():105-15. PubMed ID: 2692934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.